JIPMER introduces Online Evaluation System for Theory Exams, to launch new super-specialisation courses next year
Puducherry: With an aim to strengthen the internal evaluation process in the MBBS and postgraduate examination, the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) has introduced an online evaluation system for high-quality assessment of theory examination papers.
Apart from this, the institute is also planning to launch six new super specialisation post MD/MS courses (post doctoral fellow) in various disciplines.
These newly proposed super specialisation courses include gynaecological oncology, interventional cardiology, paediatric neurosurgery, foetal medicine and paediatric nephrology.
Further, from the next batch, JIPMER is also going to introduce elective postings for MBBS interns in the rural centres.
Referring to the issue of recently introduced online evaluation system, the Director of JIPMER, Rakesh Aggarwal told The Hindu, "The online computer-based system introduced for the evaluation of scripts of theory (internal) examinations is a leap towards going fully online for final theory papers ahead of the practical examination for graduate and post graduate courses."
He made this comment while speaking at the 13th convocation for MBBS, MD, Ph.D and other programmes at JIPMER. Dr. Aggarwal opined that this move will ensure high-quality evaluation of the theory papers.
Further, he mentioned that the admission for the new courses approved by the JIPMER Academic Committee would commence in January, 2024.
"During 2022-23, the quantitative and qualitative thrust in research witnessed an uptick in the number of extra mural grants sanctioned for projects. A total of 59 extra mural projects were sanctioned with ₹16 crore accruing as research grants. JIPMER had sanctioned intra mural grants to the tune of ₹2.1 crore to young researchers," added Dr. Aggarwal.
Further, it was disclosed that the scholarly journals published by the faculty members and students at JIPMER crossed the 1,000-mark with 1,054 publications.
Dr. Aggarwal further mentioned that an animal house building worth Rs 30 crore has been made ready and it is waiting municipal nod. He also added that a nascent bio informatics facility will be expanded.
Apart from this, the jump of JIPMER in NIRF rankings by three places in two years and securing 5th rank was pointed out by Dr. Aggarwal. In the overall NIRF rankings for all Indian Universities, the institute improved its ranking from 54th position to 39th position last year.
There are 2,220 beds in JIPMER and it registers about 8,000 OP and 500 emergency service visits every day. Dr. Aggarwal mentioned that the institute is considering additional operating theratres.
He also mentioned that over the past year, JIPMER opened a 24/7 OT neurosurgery a second ICU for anaesthesiology, a new ICU for pulmonary unit, and a 10-bed post operative ward for orthopaedics, a high dependency unit for paediatrics and a kangaroo mother care ward for neonatology. He added that this was made possible because 413 nursing officers and 80 senior residents were recruited.
Dr. Aggarwal further said that the first phase of the infrastructure plan for the Karaikal campus of JIPMER worth Rs 400 crore has been completed. Apart from this, the delegated investment board of the Union Health Ministry has approved setting up a 500-bed teaching hospital in Karaikal estimated at a cost of Rs 452 crore. The construction for the same is likely to commence this year and continue for three years.
He also added a 100-bed multi-specialty consulting unit has been made ready ar Yanam and OPD services will start in November.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.